CCL

Összesen 2 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM120196
035-os BibID:(Scopus)85189985181
Első szerző:Bedekovics Judit (orvos)
Cím:Exploring p53 protein expression and its link to TP53 mutation in myelodysplasia-related malignancies - Interpretive challenges and potential field of applications / Judit Bedekovics, Kristóf Madarász, Attila Mokánszki, Sarolta Molnár, Ágnes Mester, Zsófia Miltényi, Gábor Méhes
Dátum:2024
ISSN:0309-0167
Megjegyzések:Aims: TP53 alterations have a significant prognostic effect in myeloid neoplasms. Our objective was to investigate the TP53 gene mutation status, p53 protein expression and their relationship in dysplasia-related myeloid neoplasms with varying levels of myeloblast counts. Methods and results: A total of 76 bone marrow biopsy samples with different blast counts were analysed. Total and strong (3+) p53 expression was determined. Dual immunohistochemical staining was performed to determine the cell population associated with p53 expression. NGS analysis was performed using the Accel-Amplicon Comprehensive TP53 panel. Both p53 expression and TP53 VAF showed a significant correlation with the myeloblast ratio (P?<?0.0001); however, p53 expression was also present in other cell lineages. The VAF value exhibited a significant correlation with p53 expression. A high specificity (0.9800) was observed for TP53 mutation using the ??10% strong (3+) p53 cut-off value, although the sensitivity (0.4231) was low. Conclusions: Strong (3+) p53 expression using a ??10% cut-off value accurately predicts TP53 mutation but does not reveal the allelic state. The p53 expression is significantly influenced by myeloblast count, and histological interpretation should consider the presence of intermixed non-neoplastic marrow cells with varying physiological p53 expression.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
bone marrow
myeloblast
myelodysplasia
p53 expression
TP53 mutation
Megjelenés:Histopathology. - [Epub ahead of print] (2024). -
További szerzők:Madarász Kristóf (1996-) (biológus) Mokánszki Attila (1983-) (molekuláris biológus Ph.D hallgató) Deliné Molnár Sarolta (1990-) (patológus) Mester Ágnes Miltényi Zsófia (1975-) (belgyógyász, haematológus) Méhes Gábor (1966-) (patológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM076941
035-os BibID:(WOS)000475558500040 (Scopus)85060540723
Első szerző:Molnár Csaba (pathológus)
Cím:Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis : clinicopathological and Molecular Characteristics Clue up Pathogenesis / Csaba Molnár, Sarolta Molnár, Judit Bedekovics, Attila Mokánszki, Ferenc Győry, Endre Nagy, Gábor Méhes
Dátum:2019
ISSN:1219-4956 1532-2807
Megjegyzések:Thyroid cancer (TC) coexisting with Hashimoto's thyroiditis (HT) presents with several characteristic features including multifocality and lower clinical stages compared to de novo carcinomas but its exact biology is still not understood. We reexamined clinico-pathological and molecular correlations between Hashimoto's thyroditis and papillary thyroid cancer. A total of 262 patients with TC was evaluated who underwent thyroidectomy at the Surgical Department of the University of Debrecen. Clinical data, histology and molecular data were evaluated. Our cohort included 43 patients (16.4%) with (5 male, 38 female) and 219 (83.6%) patients without coexisting HT (48 male, 171 female). Hashimoto's thyroiditis related thyroid cancer presented predominantly (93.0% of the cases) with the papillary histological type. Multifocality was observed more frequently with coexisting HT (16/40; 40.0%) compared to cases uninvolved (45/190; 23.7%)(p?=?0.034). In contrast, lymphatic metastasis (pN1) with a significantly reduced frequency in patients with HT (4/11; 36.4%) then without HT (34/41 pN1; 82.9%)(p?=?0.002). BRAF V600E mutation could be demonstrated at significantly lower rates in cases of PTC?+?HT (32.1 vs 60.7%, p?<?0.005). High incidence, multifocality and papillary morphology strongly support a causal relation between TC and preexisting Hashimoto's thyroiditis, the latter to be considered as a preneoplastic condition promoting thyroid carcinogenesis.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Carcinoma
Clinicopathology
Hashimoto thyreoiditis
Molecular pathology
Thyroid
Megjelenés:Pathology & Oncology Research. - 25 : 3 (2019), p. 1191-1197. -
További szerzők:Deliné Molnár Sarolta (1990-) (patológus) Bedekovics Judit (1986-) (orvos) Mokánszki Attila (1983-) (molekuláris biológus Ph.D hallgató) Győry Ferenc (1969-) (kardiológus) Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Méhes Gábor (1966-) (patológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1